Literature DB >> 19943068

Intraspinal techniques for pain management in cancer patients: a systematic review.

Jeff Myers1, Vincent Chan, Virginia Jarvis, Cindy Walker-Dilks.   

Abstract

PURPOSE: This systematic review outlines current evidence regarding the effectiveness of intraspinal techniques for cancer pain and addresses practical implementation issues.
METHODS: A search of electronic databases identified systematic reviews and randomized controlled trials (RCTs) evaluating the effectiveness of intraspinal techniques in the setting of cancer pain. An environmental scan was completed via the internet to identify practice guidelines and resource documents addressing organizational and implementation issues in the delivery of intraspinal analgesia. Elements reviewed included patient selection, contraindications, monitoring, aftercare, follow-up, hospital discharge equipment, health personnel, patient education, and safety. MAIN
RESULTS: Three systematic reviews, three consensus conferences, and 12 RCTs met the inclusion criteria for evidence of effectiveness. No single systematic review or consensus conference included all relevant RCTs or specifically addressed the use of intraspinal techniques for cancer pain. Six RCTs compared intraspinal techniques alone or combined with other interventions alone or in combination, four compared different intraspinal medications, and two compared different intraspinal techniques. In general, the evidence supported the use of intraspinal techniques for cancer pain management. The two main indications consistently identified were intractable pain not controlled by other conventional medical routes and/or side effects from conventional pain management strategies preventing dose escalation. Reports indicate intraspinal analgesia is equally or more effective than conventional medical management and often associated with fewer side effects. Thirteen resource documents addressed issues surrounding the delivery of intraspinal analgesia and program implementation.
CONCLUSIONS: Intraspinal techniques monitored by an interprofessional health care team should be included as part of a comprehensive cancer pain management program.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 19943068     DOI: 10.1007/s00520-009-0784-2

Source DB:  PubMed          Journal:  Support Care Cancer        ISSN: 0941-4355            Impact factor:   3.603


  32 in total

1.  Cervical versus thoracic epidural morphine for the treatment of head and neck cancer pain.

Authors:  L Georgiou; A Louizos; C Sklavou; L Manolopoulos; I Yiotakis; G Adamopoulos
Journal:  Ann Otol Rhinol Laryngol       Date:  2000-07       Impact factor: 1.547

2.  Management of cancer symptoms: pain, depression, and fatigue.

Authors:  D Carr; L Goudas; D Lawrence; W Pirl; J Lau; D DeVine; B Kupelnick; K Miller
Journal:  Evid Rep Technol Assess (Summ)       Date:  2002-07

Review 3.  Cancer pain relief and palliative care. Report of a WHO Expert Committee.

Authors: 
Journal:  World Health Organ Tech Rep Ser       Date:  1990

4.  Validation of World Health Organization guidelines for cancer pain relief during the last days and hours of life.

Authors:  S Grond; D Zech; S A Schug; J Lynch; K A Lehmann
Journal:  J Pain Symptom Manage       Date:  1991-10       Impact factor: 3.612

5.  Practice guidelines for cancer pain management. A report by the American Society of Anesthesiologists Task Force on Pain Management, Cancer Pain Section.

Authors: 
Journal:  Anesthesiology       Date:  1996-05       Impact factor: 7.892

6.  Human skin flora as a potential source of epidural abscess.

Authors:  S Sato; T Sakuragi; K Dan
Journal:  Anesthesiology       Date:  1996-12       Impact factor: 7.892

7.  Skin disinfection before epidural catheterization: comparative study of povidone-iodine versus chlorhexidine ethanol.

Authors:  Haruyuki Kasuda; Hirokazu Fukuda; Hideaki Togashi; Kunihsa Hotta; Yoshikazu Hirai; Mutsumu Hayashi
Journal:  Dermatology       Date:  2002       Impact factor: 5.366

8.  Comparison of 0.5% intrathecal bupivacaine with 0.5% intrathecal ropivacaine in the treatment of refractory cancer and noncancer pain conditions: results from a prospective, crossover, double-blind, randomized study.

Authors:  P Dahm; C Lundborg; M Janson; C Olegård; P Nitescu
Journal:  Reg Anesth Pain Med       Date:  2000 Sep-Oct       Impact factor: 6.288

9.  Implantable drug delivery systems (IDDS) after failure of comprehensive medical management (CMM) can palliate symptoms in the most refractory cancer pain patients.

Authors:  Thomas J Smith; Patrick J Coyne
Journal:  J Palliat Med       Date:  2005-08       Impact factor: 2.947

10.  Opioid treatment for radiating cancer pain: oral administration vs. epidural techniques.

Authors:  A Vainio; I Tigerstedt
Journal:  Acta Anaesthesiol Scand       Date:  1988-04       Impact factor: 2.105

View more
  11 in total

1.  [Cancer pain in palliative medicine].

Authors:  R Laufenberg-Feldmann; R Schwab; R Rolke; M Weber
Journal:  Internist (Berl)       Date:  2012-02       Impact factor: 0.743

Review 2.  [Cancer pain in palliative medicine].

Authors:  R Laufenberg-Feldmann; R Schwab; R Rolke; M Weber
Journal:  Anaesthesist       Date:  2012-05       Impact factor: 1.041

3.  Spinal analgesia: where is the evidence?

Authors:  Eduardo Bruera; David Hui
Journal:  Support Care Cancer       Date:  2010-06-12       Impact factor: 3.603

4.  Treatment of cancer pain: Spanish Society of Medical Oncology (SEOM) recommendations for clinical practice.

Authors:  Juan A Virizuela; Yolanda Escobar; Javier Cassinello; Pablo Borrega
Journal:  Clin Transl Oncol       Date:  2012-07       Impact factor: 3.405

Review 5.  Intrathecal Analgesia for Chronic Refractory Pain: Current and Future Prospects.

Authors:  Catherine Smyth; Nadera Ahmadzai; Jason Wentzell; Ashley Pardoe; Andrew Tse; Tiffany Nguyen; Yvette Goddard; Shona Nair; Patricia A Poulin; Becky Skidmore; Mohammed T Ansari
Journal:  Drugs       Date:  2015-11       Impact factor: 9.546

6.  Neuraxial (epidural and intrathecal) opioids for intractable pain.

Authors:  Paul Farquhar-Smith; Suzanne Chapman
Journal:  Br J Pain       Date:  2012-02

Review 7.  Multidimensional Treatment of Cancer Pain.

Authors:  Weiyang Christopher Liu; Zhong Xi Zheng; Kian Hian Tan; Gregory J Meredith
Journal:  Curr Oncol Rep       Date:  2017-02       Impact factor: 5.075

8.  A successful palliative care intervention for cancer pain refractory to intrathecal analgesia.

Authors:  Akhila Reddy; David Hui; Eduardo Bruera
Journal:  J Pain Symptom Manage       Date:  2012-05-30       Impact factor: 3.612

9.  Intrathecal Drug Delivery Systems for Cancer Pain: A Health Technology Assessment.

Authors: 
Journal:  Ont Health Technol Assess Ser       Date:  2016-01-29

Review 10.  Interventional options for the management of refractory cancer pain--what is the evidence?

Authors:  Petra Vayne-Bossert; Banafsheh Afsharimani; Phillip Good; Paul Gray; Janet Hardy
Journal:  Support Care Cancer       Date:  2015-12-11       Impact factor: 3.603

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.